Sen. Laura Ellman supports SB2762 mandating insurance for seizure detection devices

Sen. Laura Ellman (D-21st) cast a yes vote on SB2762—legislation mandating health insurance coverage for seizure detection devices—during the 104th General Assembly on May 31, 2026, the Illinois Senate reported. The bill passed with a 53-5 Senate vote.

The measure’s summary describes it as: "INS-SEIZURE DETECTION DEVICE."

The summary below reflects the provisions of the legislation, as clarified for better understanding.

SB2762 would require that the majority of individual and group health benefit programs—including those provided by state and local governments, schools, HMOs, limited or voluntary health services, and Medicaid—cover prescribed seizure detection technology beginning Jan. 1, 2027. Qualifying devices are defined as those with FDA clearance designed for monitoring, forecasting, warning, or collecting data related to seizure incidents. The legislation prohibits prior authorization requirements and cap on most forms of patient cost sharing, with exceptions to maintain compliance with high-deductible health plans linked to health savings accounts. Upon being signed into law, the bill would take effect immediately.

For SB2762, the noted action was 'House Floor Amendment No. 3 Senate Concurs'.

Ellman earned her Bachelor of Science from Grinnell College in 1987.

A member of the Democratic Party, Ellman began serving in the Illinois State Senate for the 21st District in 2019, succeeding former state senator Michael Connelly.

The legislative process in Illinois follows multiple procedural steps, starting with a bill’s introduction, consideration by committee, discussion and votes in both Senate and House, and the potential for the governor’s approval or veto. Illinois’ General Assembly is biennial, and although lawmakers file thousands of bills each term, relatively few are enacted into law.